Cargando…
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL). Herein we show by genomic profiling of a large cohort of mPPGLs that high mutational load, microsatellite instability and somatic copy-number...
Ejemplares similares
-
Analysis of Telomere Maintenance Related Genes Reveals NOP10 as a New Metastatic-Risk Marker in Pheochromocytoma/Paraganglioma
por: Monteagudo, María, et al.
Publicado: (2021) -
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
por: Mellid, Sara, et al.
Publicado: (2023) -
Novel DNMT3A Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
por: Mellid, Sara, et al.
Publicado: (2020) -
A Novel Approach for the Identification of Pharmacogenetic Variants in MT-RNR1 through Next-Generation Sequencing Off-Target Data
por: Lanillos, Javier, et al.
Publicado: (2020) -
Comprehensive molecular analysis of immortalization hallmarks in thyroid cancer reveals new prognostic markers
por: Montero‐Conde, Cristina, et al.
Publicado: (2022)